SOD is shown as a therapeutic target for preventing cognitive dysfunction development and reducing its severity in cerebral small vessel disease, which also has enlightenment for the treatment of PD with cognitive impairment (Zhu et al., 2019). The gene discussed is SOD1; the disease is Parkinson disease.